DADC
CDMO

D.A. Davidson & Co’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

D.A. Davidson & Co’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-457
Closed -$2K – 2456
2017
Q1 		$2K Buy
+457
New +$1.53K ﹤0.01% 2277

Other funds holding CDMO

TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
BAS
Brown Advisory Securities Baltimore, Maryland $27.3M AUM 10.67% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

D.A. Davidson & Co's CDMO Position: Q2 2017 in Review

D.A. Davidson & Co sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2017, closing a stake of 457 shares — an estimated $2K sold.

D.A. Davidson & Co first reported a position in CDMO in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 60 funds tracked by Wall St. Rank hold CDMO as of Q2 2017.

  • D.A. Davidson & Co reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 457 Avid Bioservices, Inc. Common Stock shares in Q2 2017, an estimated $2K.
  • D.A. Davidson & Co first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • D.A. Davidson & Co's Avid Bioservices, Inc. Common Stock position peaked at $2K in Q1 2017.
  • 60 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2017.

Based on D.A. Davidson & Co's 13F filing for Q2 2017, filed 11 Aug 2017.